June 23, 2025In drug development, and especially for smaller and medium-sized biotech companies, consistency is everything. From regulatory pathways to R&D timelines…
June 23, 2025As a medicinal chemist with experience in large pharmaceutical companies, I’ve spent my career designing and optimizing drug candidates. But…
June 11, 2025The landscape of analytical development is continually evolving. With the introduction of ICH Q14: Analytical Procedure Development, the pharmaceutical and…
May 21, 2025With a focus on people, process, and technology, Syner-G BioPharma Group empowers life science organizations with the knowledge and expertise…
May 21, 2025In order to maintain competitiveness, life science organizations are leveraging technology now more than ever to enhance decision-making, create innovative…
May 20, 2025The ongoing U.S.-China trade war, now entering its seventh year, has evolved beyond tariffs into a broader strategic contest over…
January 15, 2025Developing the manufacturing process can be one of the most time- and resource-intensive aspects of pharmaceutical development. Staying competitive requires…
December 11, 2024In the ever-evolving landscape of cancer treatment, timely access to effective therapies is crucial. The FDA’s Real-Time Oncology Review (RTOR)…- September 6, 2024In the first instalment of our multi-part series, the key differences between biologic drugs and traditional small molecule drugs such…
August 19, 2024In the dynamic landscape of biopharmaceutical development, adherence to evolving international standards is crucial. The recent updates from International Council…
